European Pharmaceutical Review

NOVEMBER 23, 2023

Following the UK government’s recent announcement of a £520 million funding boost for UK manufacturing, a new Oligonucleotide Manufacturing Innovation Centre of Excellence in Scotland will develop innovative and sustainable techniques for these medicines. There is a massive gap in the supply and demand for this innovative technology.

Manufacturing 81

Manufacturing Medicine Government Pharmaceutical 81

European Pharmaceutical Review

OCTOBER 11, 2023

As part of newly acquired assets from live biotherapeutics products (LBP) manufacturer Federation Bio, Kanvas Biosciences now has two active microbiome-based clinical programmes. This acquisition allows us to manufacture and clinically investigate complex microbial consortia much faster than previously envisioned.

Manufacturing 75

Manufacturing Medicine Patients Leads 75

European Pharmaceutical Review

JUNE 11, 2023

The US Food and Drug Administration (FDA) has approved commercial production at Bristol Myers Squibb’s newest cell therapy manufacturing facility in Devens, Massachusetts. The site is a “critical component” of BMS’ expanding global cell therapy manufacturing footprint, the company said. “The

Manufacturing 89

Manufacturing Food and Drug Administration FDA Engineering 89

European Pharmaceutical Review

SEPTEMBER 28, 2023

According to the European Federation of Pharmaceutical Industries and Associations (EFPIA), more than 600 essential medicines are at risk if a proposed restriction on the use of fluorinated substances, per- and polyfluoroalkyl substances (PFAS) across pharmaceutical manufacturing in the EEA, is implemented.

Pharmaceutical manufacturing 93

Pharmaceutical manufacturing Manufacturing Pharmaceutical Medicine 93

Pharmaceutical Technology

SEPTEMBER 8, 2022

Pharmaceutical solid dose manufacturing companies in contract marketing segment have gained a vital position in pharmaceutical formulations. Pharmaceutical solid dosage forms are the most popular in the pharmaceutical industry and are one of the most used drug delivery methods across patient groups.

Manufacturing 40

Manufacturing Leads Pharmaceutical Marketing 40

European Pharmaceutical Review

DECEMBER 4, 2023

To address these issues, companies should adopt more advanced production strategies such as continuous flow chemistry, as they can shorten manufacturing processes, increase productivity and throughput. Simultaneously, there is increasing need for stringent quality control and traceability throughout the supply chain to ensure patient safety.

Pharmaceutical manufacturing 87

Pharmaceutical manufacturing Manufacturing Pharmaceutical Pharmaceutical products 87

European Pharmaceutical Review

MAY 1, 2023

After agreeing to acquire a US-based manufacturing facility and its operations from Novartis, Bristol Myers Squibb (BMS) adds in-house production of viral vectors to its capabilities. This move will support the expansion of the company’s global cell therapy manufacturing network.

Manufacturing 78

Manufacturing Engineering Networking Patients 78

European Pharmaceutical Review

JANUARY 27, 2023

The UK will be the first country to introduce a tailored framework for the regulation of innovative medicines manufactured at the point where a patient receives care, the Medicines and Healthcare products Regulatory Agency (MHRA) has announced. Clear regulatory expectations and allowing easier product development.

Manufacturing 85

Manufacturing Medicine Consulting Engineering 85

European Pharmaceutical Review

MARCH 1, 2023

million collaboration between the Centre for Process Innovation (CPI), AstraZeneca, Novartis, and The University of Manchester aims to revolutionise oligonucleotide manufacture. The three-year project is planned to translate “…approaches to oligonucleotide synthesis into sustainable manufacturing processes.

Manufacturing 83

Manufacturing Medicine Pharmaceutical Pharma 83

European Pharmaceutical Review

FEBRUARY 21, 2023

Crucially, January 2023 marked a key moment: the Medicines and Healthcare products Regulatory Agency (MHRA) granted Celadon Pharmaceuticals the first good manufacturing practice (GMP) registration since legalisation in 2018 for high Δ9-tetrahydrocannabinol (THC) cannabis active pharmaceutical ingredient (API).

Medicine 127

Medicine Manufacturing Specialization Pharmaceutical 127

Fierce Pharma

NOVEMBER 8, 2023

While Novo Nordisk struggles with manufacturing concerns and patient coverage on its long-acting insulin Levemir, Bayer missed a primary endpoint in a confirmatory trial for its P13K inhibitor Aliq | While Bayer's P13K Aliqopa couldn't prove its worth in a confirmatory trial, Novo's Levemir faced manufacturing issues and troubles with (..)

Manufacturing 130

Manufacturing Marketing Leads Patients 130

Pharmaceutical Technology

MARCH 10, 2023

On 10 March, the National Health Service Blood and Transplant (NHSBT) opened a new Clinical Biotechnology Centre (CBC) with the aim of improving the UK’s ability to develop and manufacture cell and gene therapies. This is important due to the UK’s currently limited short-scale manufacturing capacity.

Manufacturing 105

Manufacturing Distribution Medicine Patients 105

European Pharmaceutical Review

DECEMBER 23, 2022

With over 90,000 employees across the globe, Sanofi supplies over 5 billion doses of medicines and vaccines every year, supporting the health needs of millions of patients in more than 170 countries. Standardise manufacturing . Digitalise manufacturing: artificial intelligence and machine learning.

Manufacturing 80

Manufacturing Networking Medicine Electronics 80

World of DTC Marketing

MARCH 23, 2022

Do patients care? Do patients care? If you’re a cancer patient and your oncologist is prescribing a drug approved via accelerated Approval, are you going to refuse treatment? Should patients be made aware that the drug they are being prescribed is an “accelerated approval drug”? Of course not.

Patients 200

Patients FDA Doctors Physicians 200

Pharmaceutical Technology

MARCH 31, 2023

Moderna has finalised an agreement with the government of the Republic of Kenya to establish an mRNA manufacturing facility in the country. The company is also committed to establishing mRNA manufacturing facilities in Australia, Canada, the US and the UK.

Manufacturing 105

Manufacturing Government Medicine Healthcare 105

European Pharmaceutical Review

JUNE 15, 2023

This approach can also help determine the appropriate manufacturing processes, sterilisation methods, and maintenance procedures. Importantly, they identify potential sources of microbial contamination and assess their risk to patients. Medical devices are essential tools for diagnosing, monitoring and treating a variety of conditions.

Manufacturing 78

Manufacturing Medical Safety Transportation 78

European Pharmaceutical Review

NOVEMBER 16, 2022

As the emphasis of new drug development gravitates towards new, ground-breaking therapies and vaccines, the requirements of manufacturing sites, equipment and processes need to be appropriate for this new environment. That is because of the relative expense of emerging therapies and the pressure on pricing for continuing product lines.

Manufacturing 109

Manufacturing Pharma Biopharma Management 109

Pharmaceutical Technology

JUNE 8, 2023

Mendus has entered an alliance with NorthX Biologics to co-establish a cell therapy manufacturing unit for its lead asset, vididencel, in Sweden. Mendus has partnered with NorthX and Swedish investment firm Flerie Invest, which will make an initial investment of Skr90m ($8.25m) in the manufacturing unit.

Manufacturing 52

Manufacturing Leads Patients Medicine 52

Healthcare Success

MAY 9, 2022

The QR code allows hospitals and healthcare providers to satisfy this need with immediate physician-patient interaction and engagement – all through smartphones and tablets. . In this blog post, you’ll learn: Why QR codes have made a comeback, When to use them, And, 8 ways to improve the patient experience and drive leads with QR codes. .

Leads 52

Leads Patients Healthcare Provider Healthcare 52

Pharmaceutical Technology

SEPTEMBER 5, 2022

Payers ensure the delivery of the best possible health outcomes to the patients from their financial plan. Pharmaceutical Technology has listed the leading payers in pharma based on its intel, insights, and decades-long experience in the sector. Patient education programmes regarding the administration of medications and therapies.

Leads 59

Leads Pharmaceutical Media Medical 59

European Pharmaceutical Review

OCTOBER 7, 2022

A market report has projected that the global oral solid dosage (OSD) contract manufacturing market is expected to be worth $54.7 Data showed that worldwide, oral solids are the most popular mode of drug delivery due to being highly cost-effective and offering simple manufacturing processes.

Manufacturing 81

Manufacturing Marketing Side effects Transportation 81

pharmaphorum

OCTOBER 14, 2022

DiCE includes 20 organisations from nine countries, representing the manufacturing industry, research, and recycling sectors. The post Janssen leads effort to cut waste in digital health devices appeared first on. Great to have you on board @ForumWeee , we look forward to the next four years of collaboration!

Leads 121

Leads Electronics Ethics Healthcare 121

pharmaphorum

JULY 21, 2022

UQ’s Dr Keith Chappell – one of the discoverers of the molecular clamp technology along with Prof Paul Young and Dr Daniel Watterson – will serve as lead scientific advisor to the new biotech. ” The post Ex-GSK vaccine chief to lead new UK biotech Vicebio appeared first on. . Dr Emmanuel Hanon. ” He said.

Leads 93

Leads Manufacturing Training Medical 93

Pharmaceutical Technology

APRIL 25, 2023

Forge Biologics has received a qualified person (QP) declaration to manufacture adeno-associated virus (AAV) gene therapies to support European clinical programmes. The company stated that a European QP has completed an in-depth audit at its manufacturing facility in Columbus, Ohio, US.

Manufacturing 52

Manufacturing Food and Drug Administration Distribution Medicine 52

Pharmaceutical Technology

MAY 2, 2023

Marker Therapeutics has reached a non-dilutive agreement to sell cell manufacturing assets to CellReady for $19m in cash. CellReady is a newly created contract development and manufacturing organisation (CDMO) founded by Marker board member and co-founder John Wilson. Both firms expect to complete the deal on 26 June 2023.

Manufacturing 52

Manufacturing Leads Management Pharmaceutical 52

Infuse Medical

MAY 2, 2024

In the healthcare Operations field, achieving the best possible patient outcomes is paramount. This means ensuring patients not only understand their diagnosis but are also empowered to participate actively in their treatment plan. It utilizes computer-generated simulations to create realistic and interactive environments.

Patients 52

Patients Education Healthcare Healthcare 52

European Pharmaceutical Review

APRIL 26, 2023

Built to deliver Moderna’s ten-year strategic partnership with the UK government, announced in March 2023, the MITC will incorporate research, development and a manufacturing facility for mRNA vaccines. Harwell Science and Innovation Campus Harwell is the UK’s leading science and innovation campus.

Manufacturing 52

Manufacturing Government Management Leads 52

European Pharmaceutical Review

MARCH 7, 2024

Last month, construction began on Europe’s first industrial-scale facility dedicated to the production of lead-212 based radioligand therapies. percent for the gastroenteropancreatic neuroendocrine tumours (GEP-NET) patients who had never received radioligand therapy).

Manufacturing 52

Manufacturing Food and Drug Administration Marketing Management 52

Impetus Digital

JANUARY 30, 2023

Medications and supplies must be handled with the utmost care, often needing to comply with strict temperature regulations and changing demands from patients and providers that vary depending on the country. Add this to infrastructure challenges like cold storage or delays, and it’s no wonder patient needs are not always put first.

Pharmaceutical 68

Pharmaceutical Patients Safety Distribution 68

Pharmaceutical Technology

SEPTEMBER 8, 2022

Speciality pharmacies play a crucial role in medication dosing, disease and side effects management, and patient care. The expert services rendered by them help in improving patient outcomes, minimising costs of the healthcare system, improving medicinal adherence and persistency and saving clinicians’ time.

Specialization 45

Specialization Leads Pharma Side effects 45

Pharmaceutical Technology

MAY 8, 2023

Microbiota restoration therapy is a key innovation area in immuno-oncology Microbiota restoration therapy can be composed of human faecal material containing viable gut flora from a patient or donor, and include a diluent and a cryoprotectant. Probiotical is a manufacturer of probiotics and synbiotics products.

Leads 98

Leads Pharmaceutical Manufacturing Healthcare 98

European Pharmaceutical Review

AUGUST 19, 2022

Rising demand for therapeutics, especially in developing markets, is expected to expand the global pharmaceutical contract manufacturing market to $130.2 billion by 2026, as contract manufacturing organisations increasingly adopt newer and efficient ways to package products, increasing demand for new machinery. billion by 2026.

Manufacturing 87

Manufacturing Marketing Pharma Healthcare 87

Pharmaceutical Technology

SEPTEMBER 6, 2022

The pharmaceutical supply chain is a global and complex network that includes a wide range of stakeholders such as pharmaceutical manufacturers, wholesale distributors, and pharmacy benefit managers (PBM), to ensure efficient and timely delivery of medications to the patients.

Pharmaceutical 59

Pharmaceutical Leads Pharma Transportation 59

pharmaphorum

JUNE 27, 2022

7008), which allows manufacturers to share vital information with healthcare payers and plans while treatments are pending Food and Drug Administration (FDA) approval, was passed by the House of Representatives and is awaiting approval in the Senate. The AMCP backed bill (H.R. The AMCP backed bill (H.R. The history of PIE.

Food and Drug Administration 77

Food and Drug Administration Medical Patients FDA 77

Pharmaceutical Technology

SEPTEMBER 8, 2022

Pharmaceutical compounding is a method of preparing personalised medications for patients by mixing the individual ingredients in the exact strength and dosage form required by the patient. Large-scale manufacturing. Large-scale manufacturing. Discover the top pharmaceutical compounding companies in contract marketing.

Leads 52

Leads Pharmaceutical Marketing Medicine 52

European Pharmaceutical Review

MAY 2, 2024

In this Q&A, Sigma elucidated on the current key trends and challenges within field, with two major obstacles being the “translatability of the preclinical data to the human patient and the manufacturability of the drugs being developed” How has the development landscape for biologics evolved over the last several years?

Medicine 96

Medicine Manufacturing Biopharma Engineering 96

Pharmaceutical Technology

JANUARY 20, 2023

Increasing manufacturing capacity for pandemic prevention “The other piece we are working on is … how do we build manufacturing capacity around the world?”, The biotech has also made plans to expand manufacturing capacity elsewhere. The manufacturing expansion plans go beyond Covid-19 vaccines and therapeutics. “We

Manufacturing 98

Manufacturing Government Sales Pharmaceutical 98